Indian drugs sales drop to 8-month low

09/24/2013 | MedCityNews.com

Sales of drugs in India declined from nearly $1.11 billion in July to $1.09 billion in August, according to pharmaceutical market researcher IMS Health India. The new price controls on 348 essential medicines appeared to have an impact, according to this article; in August, their sales fell 9% from a year ago.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA